The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMXC.L Share News (MXC)

  • There is currently no data for MXC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Knights Group, Water Intelligence tie up acquisitions

Mon, 01st Nov 2021 16:45

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

OnTheMarket PLC - Aldershot, England-based operator of online property search portal OnTheMarket.com - Says initial consideration paid for the 80% of shares in Glanty Ltd acquired in May 2021 is being reduced, with the return by the vendors of 163,154 shares. "This is equivalent to a reduction of GBP147,000 based upon the share price used in the initial purchase of the 80% of Glanty. It arises under the previously announced post-completion adjustment mechanism based upon Glanty's net cash-net debt and actual working capital position as at completion," company says.

----------

TMT Investments PLC - venture capital investor in high-growth technology companies - Notes investee Volumetric Biotechnologies Inc acquired by 3D Systems. Deal made up of initial payment of USD45 million with USD355 million of further consideration due on an earnout basis subject to the achievement of certain milestones. "TMT invested USD200,000 in Volumetric in July 2020 by way of a simple agreement for future equity with a 20% discount on conversion subject to a valuation cap of USD12.5 million, which TMT expects will be converted and sold as part of the acquisition," company says.

----------

Sound Energy PLC - Morocco-focused upstream gas company - Agrees extension to negotiating period with Afriquia Gaz for Phase 1 LNG sale & purchase agreement, which is now required to be satisfied by November 30, 2021. "The LNG SPA is conditional upon fulfilment of certain conditions precedent and the extension now agreed is expected to allow those conditions precedent not yet satisfied, relating to the plant development contract, financing and remaining regulatory approvals to be documented contemporaneously," company says. Executive Chair Graham Lyon says he is confident deal will be completed.

----------

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Says Israeli Ministry of Health approves dosing study for CimetrA, company's proprietary treatment for the effects of Covid. "The study will incorporate key parameters including determining the most effective dosage of the treatment, a full safety and pharmacovigilance profile, in addition to an extensive pharmacokinetic profile to outline the registration and administrative process of approval for sale and use. The study will further examine the anti-inflammatory and immune-modulatory effects of CimetrA through Cytokine level monitoring," company explains. Company will recruit 240 patients in sites located in Israel, South Africa, the US, and Russia.

----------

Knights Group Holdings PLC - Newcastle-under-Lyme-based legal and professional services - Agrees to acquire law firm Archers Law LLP, based in Stockton-on-Tees, on a debt free, cash free basis for a total consideration of GBP5.2 million. Deal will be made of initial consideration of GBP3.7 million, made of GBP2.1 million in cash and GBP1.6 million from 395,060 new shares, along with deferred cash consideration of GBP1.5 million to be paid in equal instalments over the three years. Deal will paid from existing facilities, company notes. Chief Executive David Beech says: "The acquisition allows us to build on the existing strong presence we have established in Yorkshire in recent years and provides a compelling platform for future organic growth in the North East." Separately, company agrees new extended revolving credit facility with HSBC UK, Allied Irish Bank and Lloyds Bank - replacing existing facility with same lenders. The facility provides total committed funding of GBP60 million until October 2024, split equally between the three lenders.

----------

nanosynth Group PLC - digital monitoring and safeguarding systems manufacturer formerly known as Remote Monitored Systems - Returns control of wholly-owned subsidiary Cloudveil Ltd, to Cloudveil's founder, Antony Hugo Gillum-Webb, by transferring company's shares in Cloudveil to founder for nominal consideration, effective immediately. Disposal is in line with the board's strategy which is to "focus on the synthesis and application of the company's core capabilities". Also says John Richardson resigns from board as executive director, effective immediately, to focus on product management activities within P2F, the company's main subsidiary. Chair Antony Legge says: "The disposals of Gyrometric and Cloudveil are the last steps in our refocussing strategy. With the opportunities available to us, it is vital our management and financial resources are concentrated on realising returns for shareholders by exploiting our strong position within the nano-particle sector."

----------

Water Intelligence PLC - California-based environmental services and technology company - Completes acquisition of Wat-er-save Services Ltd, a UK provider of leak detection, repair and water infrastructure services to UK commercial customers including universities and leisure resorts. "The transaction is operationally strategic and earnings accretive for Water Intelligence shareholders," company says. Adds: "Strategically, today's acquisition provides the group with a more substantial sales footprint in the UK. It accelerates the group's 2022 growth target in the UK as Water Intelligence International draws on its execution experience to provide a broader suite of solutions to residential, commercial and municipal customers in the UK." Purchase price is GBP700,000 on a cash-free, debt-free basis.

----------

Ethernity Networks Ltd - Networking and security solutions provider based in Israel - Receives final investment, of GBP750,000, under investment deal with 5G Innovation Leaders Fund LLC, first agreed in September 2020. The 5G Fund will make the investment in new shares, valued at GBP823,500. The proceeds from the investment will be used by the company for general corporate and working capital purposes. Chief Financial Officer Mark Reichenberg says: "The company would like to thank 5G Fund for committing to the agreement in September last year and for their continued support through the duration of the agreement to this final investment."

----------

Volex PLC - Hampshire, England-based Volex electronic components maker - Completes acquisition of US-based manufacturer of electronic supplies Irvine Electronics Inc, first announced in mid-August, for USD16.4 million in cash. Deal was funded from company's existing debt facilities. Executive Chair Nat Rothschild says: "The completion of the Irvine acquisition further increases our geographic coverage and technical capabilities in the key North American market. Irvine complements the recently announced acquisition of Terminal & Cable TC Inc, a military wiring harness supplier. This supports our strategic intent to develop Volex's presence in the defence market, broadening our capabilities in this attractive sector."

----------

Versarien PLC - Cheltenham, Gloucestershire-based advanced materials engineer - Subsidiary 2-DTech Ltd wins GBP93,000 from UK Department for Transport to develop an innovative asymmetric pseudo-capacitor power pack as part of GBP652,000 funding by UK government for Project Supportive. "The objective is for this pack to be used in container shuttles, vehicles that transport shipping containers, at ports all over the world. Currently these vehicles are powered by diesel engines and are a sizable hurdle when it comes to transitioning maritime infrastructure to zero emissions by 2050," company says. Project Supportive funding is to help design and develop technologies to help reduce greenhouse gas emissions by the UK's maritime sector.

----------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
1 Sep 2022 17:52

TRADING UPDATES: Strong interim results from Johnson Service, Eurocell

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
25 Aug 2022 16:26

TRADING UPDATES: Malvern revenue jumps; Rockwood eyes Main Market

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
18 Aug 2022 11:57

IN BRIEF: Graft Polymer wins first commercial order for GraftBio

Graft Polymer (UK) PLC - London-based company focused on the development and production of polymer modification, biological supplements, and nano-drug delivery systems - Wins first commercial purchase order for its GraftBio division. Order for 50,000 units of its anti-inflammatory supplement, ArtemiC Rescue from MGC Pharmaceuticals PLC. Order worth around USD1 million. Production to start immediately. Delivery expected over the next three months. Chief Executive Victor Volduev says he expects follow-on orders in the coming quarters.

Read more
17 Aug 2022 11:12

MGC shares rise on USD1 million order for ArtemiC

(Alliance News) - MGC Pharmaceuticals Ltd shares were lifted on Wednesday after it announced a USD1 million order for its neutraceutical, ArtemiC.

Read more
15 Aug 2022 17:31

IN BRIEF: MGC Pharma's CannEpil found safe for driving in study

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Says clinical study results for its epilepsy treatment, CannEpil, are complete. The study found CannEpil to be safe for post-treatment driving activities. It used a driving simulator to test whether the drug caused somnolence, ie drowsiness, or impairs cognition. It was sponsored by Cannvalate Australia, and conducted by the Centre of Human Psychopharmacology at Swinburne University of Technology, under the Medical Cannabis Research Collaboration.

Read more
5 Aug 2022 14:58

TRADING UPDATES: 4D Pharma warns of wind-up; Star Phoenix files claim

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and Wednesday and not separately reported by Alliance News:

Read more
29 Jul 2022 19:36

TRADING UPDATES: Walker Crips assets grow; Minoan interim loss narrows

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
28 Jul 2022 20:08

TRADING UPDATES: Scottish American outperforms; Amte picks Dundee

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
25 Jul 2022 21:53

IN BRIEF: MGC Pharmaceuticals quarterly sales "strong"

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Says "strong" quarterly sales continue, notes AUD1.6 million, about GBP923,000, in cash receipts during three month period to June 30. In 12-month period, records AUD6.1 million in cash receipts.

Read more
14 Jul 2022 21:44

TRADING UPDATES: Shield closer to Canada approval; Angle plans raise

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
8 Jul 2022 14:19

IN BRIEF: MGC Pharmaceuticals wins approval for Covid study, shares up

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Receives approval from South African Health Products Regulatory Authority for a Phase 2b dose finding study of its nanoparticle formulation CimetrA on patients diagnosed with Covid-19.

Read more
6 Jul 2022 20:08

IN BRIEF: MGC Pharmaceuticals launches medical data app ZAM

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Says it is set to launch a real-time data collection application, ZAM, for use across the pharmaceutical and health care sectors, in collaboration with software development company, Caba Tech. The app will be available during the third quarter and will enable patients to log their medical history and monitor their medication use. ZAM, through the collection the patient data, will also provide users with a more complete understanding of their health and treatments, it says.

Read more
27 Jun 2022 20:27

IN BRIEF: MGC's CimetrA shows promise beyond Covid applications

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Says preliminary results from pre-clinical in vitro study of CimetrA show it could have "wide-ranging application" as anti-inflammatory treatment. This is through the treatment's modulation of the production of pro-inflammatory cytokines. The study was undertaken by Israeli contract research organisation, Science in Action. Results support previous findings from a 2020 study into Covid-19, which showed CimetrA modulates the body's production of cytokines, which can lead to a cytokine storm, a type of severe immune reaction. New results support the potential of CimetrA to have a wider-ranging application as anti-inflammatory treatment, beyond the treatment of Covid-19 symptoms.

Read more
24 Jun 2022 10:13

IN BRIEF: MGC Pharma moves ahead with Covid-19 treatment in US

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Progresses plans to begin US clinical trial for its Covid-19 treatment CimetrA, as MGC and AMC Holdings Inc executives meet with department heads from the University of South Florida. Parties also discuss regulatory approvals for phytocannabinoid medicines CogniCann and CannEpil in the US for early patient access schemes. Says US market access and distribution agreement has been signed with minimum orders of USD24 million over three years, including CimetrA.

Read more
16 Jun 2022 13:43

IN BRIEF: MGC Pharmaceuticals completes research study on brain cancer

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Completes an in-vitro preclinical research study with the National Institute of Biology into the use of cannabinoids to treat brain cancer. The company says the study, undertaken on 30 biopsy samples from 18 patients over a period of three years, sought to determine the optimal formulation for the treatment of Glioblastoma, a form of brain cancer. The study showed that MGC Pharma's proprietary formulations were cytotoxic to Glioblastoma tumour and stem cells, reducing the cells' viability and inducing caspase-dependent cell apoptosis, or cell death.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.